Whole Exome Sequencing Market Research Report - Global Forecast till 2030

全エクソームシーケンシングの市場規模、動向、製品別の業界見通し(キット(DNA断片化、末端修復、Aテーリングおよびサイズ選択キット、ライブラリー調製、ターゲットエンリッチメント)シーケンサー、サービス(シーケンスサービス、データ分析、その他)技術(SBS、イオンセミコンダクターシーケンシング、その他)アプリケーション(診断(がん診断、単一遺伝子性疾患、単一遺伝子型糖尿病、その他)、創薬および開発、農業および動物研究、その他)、エンドユーザー(研究センターおよび政府機関、製薬およびバイオテクノロジー企業、その他)-2030年までの予測

ID: MRFR/HC/7291-CR | May 2020 | Region: Global | 164 Pages         

1 EXECUTIVE SUMMARY

1.1 OVERVIEW 17

1.1.1 MARKET SYNOPSIS 17

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 18

2.2 RESEARCH OBJECTIVE 18

2.3 LIST OF ASSUMPTIONS 19

3 RESEARCH METHODOLOGY

3.1 OVERVIEW 21

3.2 DATA MINING 21

3.3 SECONDARY RESEARCH 22

3.4 PRIMARY RESEARCH 23

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24

3.5 FORECASTING TECHNIQUES 24

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25

3.6.1 BOTTOM-UP APPROACH 26

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 28

3.8 VALIDATION 28

4 MARKET DYNAMICS

4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 INCREASING USE OF EXOME SEQUENCING AND FUNDING PROGRAMS 30

4.2.2 COSTE-EFFECTIVE COMPARED TO OTHER SEQUENCING METHODS 30

4.2.3 INCREASING PRODUCT LAUNCHES BY MAJOR PLAYERS 30

4.2.4 DRIVERS IMPACT ANALYSIS 31

4.3 RESTRAINTS 32

4.3.1 UNFAVORABLE REGULATORY POLICIES 32

4.3.2 SOCIAL/ETHICAL/LEGAL ISSUES 32

4.3.3 RESTRAINTS IMPACT ANALYSIS 32

4.4 OPPORTUNITIES 33

4.4.1 CLOUD-BASED TECHNOLOGY TO MANAGE THE DATABASE 33

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 34

5.1.1 THREAT OF NEW ENTRANTS 35

5.1.2 BARGAINING POWER OF SUPPLIERS 35

5.1.3 THREAT OF SUBSTITUTES 35

5.1.4 BARGAINING POWER OF BUYERS 35

5.1.5 INTENSITY OF RIVALRY 35

5.2 VALUE CHAIN ANALYSIS 36

5.2.1 R&D AND DESIGNING 37

5.2.2 MANUFACTURING 37

5.2.3 DISTRIBUTION 37

5.2.4 MARKETING & SALES 37

5.2.5 POST-SALES MONITORING 37

6 WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

6.1 INTRODUCTION 38

6.2 KITS 39

6.2.1 DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION KITS 40

6.2.2 LIBRARY PREPARATION 40

6.2.3 TARGET ENRICHMENT 41

6.3 SEQUENCER 41

6.4 SERVICES 42

6.4.1 SEQUENCING SERVICES 42

6.4.2 DATA ANALYSIS (BIOINFORMATICS) 43

6.4.3 OTHERS 43

7 WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

7.1 INTRODUCTION 44

7.2 SEQUENCING BY SYNTHESIS (SBS) 45

7.3 ION SEMICONDUCTOR SEQUENCING 46

7.4 OTHERS 46

8 WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

8.1 INTRODUCTION 47

8.2 DIAGNOSTICS 48

8.2.1 CANCER DIAGNOSTICS 49

8.2.2 MONOGENIC (MENDELIAN) DISORDERS 50

8.2.3 MONOGENIC TYPES OF DIABETES 50

8.2.4 MOVEMENT DISORDERS 51

8.2.5 HIV 51

8.2.6 OTHERS 52

8.3 DRUG DISCOVERY AND DEVELOPMENT 52

8.4 AGRICULTURE AND ANIMAL RESEARCH 53

8.5 OTHERS 53

9 WHOLE EXOME SEQUENCING MARKET, BY END USER

9.1 INTRODUCTION 54

9.2 RESEARCH CENTERS AND GOVERNMENT INSTITUTES 55

9.3 HOSPITALS AND DIAGNOSTICS CENTERS 56

9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 56

9.5 OTHERS 57

10 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY REGION

10.1 INTRODUCTION 58

10.2 AMERICAS 60

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.2.1 NORTH AMERICA 63

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.2.1.1 US 66

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.2.1.2 CANADA 69

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.2.2 LATIN AMERICA 71

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3 EUROPE 74

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1 WESTERN EUROPE 77

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.1 GERMANY 80

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.2 FRANCE 83

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.3 UK 85

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.4 ITALY 88

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.5 SPAIN 90

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.6 REST OF WESTERN EUROPE 93

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.2 EASTERN EUROPE 95

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4 ASIA-PACIFIC 98

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.1 JAPAN 101

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.2 CHINA 104

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.3 INDIA 106

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.4 SOUTH KOREA 109

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.5 AUSTRALIA 111

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.6 REST OF ASIA-PACIFIC 114

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.5 MIDDLE EAST & AFRICA 117

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.5.1 MIDDLE EAST 120

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.5.2 AFRICA 123

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

11 COMPETITIVE LANDSCAPE: GLOBAL WHOLE EXOME SEQUENCING MARKET

11.1 OVERVIEW 126

11.2 COMPETITIVE ANALYSIS 126

11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL WHOLE EXOME SEQUENCING MARKET 126

11.4 MARKET SHARE ANALYSIS 128

11.5 COMPETITIVE BENCHMARKING 129

11.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 130

11.6.1 COLLABORATIONS & PARTNERSHIPS 130

11.6.2 EXPANSIONS 131

11.7 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 131

11.7.1 SALES AND OPERATING PROFIT MARGIN 131

11.7.2 R&D EXPENDITURE 132

12 COMPANY PROFILES

12.1 ILLUMINA INC. 133

12.1.1 COMPANY OVERVIEW 133

12.1.2 FINANCIAL OVERVIEW 134

12.1.3 PRODUCTS/SERVICES OFFERED 135

12.1.4 KEY DEVELOPMENTS 135

12.1.5 SWOT ANALYSIS 136

12.1.6 KEY STRATEGIES 136

12.2 BGI 137

12.2.1 COMPANY OVERVIEW 137

12.2.2 FINANCIAL OVERVIEW 138

12.2.3 PRODUCTS/SERVICES OFFERED 138

12.2.4 KEY DEVELOPMENTS 139

12.2.5 SWOT ANALYSIS 139

12.2.6 KEY STRATEGIES 139

12.3 EUROFINS SCIENTIFIC 140

12.3.1 COMPANY OVERVIEW 140

12.3.2 FINANCIAL OVERVIEW 140

12.3.3 PRODUCTS/SERVICES OFFERED 141

12.3.4 EUROFINS SCIENTIFIC: KEY DEVELOPMENTS 141

12.3.5 SWOT ANALYSIS 142

12.3.6 KEY STRATEGIES 142

12.4 THERMO FISHER SCIENTIFIC 143

12.4.1 COMPANY OVERVIEW 143

12.4.2 FINANCIAL OVERVIEW 144

12.4.3 PRODUCTS/SERVICES OFFERED 145

12.4.4 KEY DEVELOPMENTS 145

12.4.5 SWOT ANALYSIS 146

12.4.6 KEY STRATEGIES 146

12.5 AGILENT TECHNOLOGIES, INC. 147

12.5.1 COMPANY OVERVIEW 147

12.5.2 FINANCIAL OVERVIEW 147

12.5.3 PRODUCTS/SERVICES OFFERED 148

12.5.4 KEY DEVELOPMENTS 148

12.5.5 SWOT ANALYSIS 149

12.5.6 KEY STRATEGIES 149

12.6 F. HOFFMANN-LA ROCHE LTD 150

12.6.1 COMPANY OVERVIEW 150

12.6.2 FINANCIAL OVERVIEW 151

12.6.3 PRODUCTS/SERVICES OFFERED 151

12.6.4 KEY DEVELOPMENTS 152

12.6.5 SWOT ANALYSIS 152

12.6.6 KEY STRATEGIES 152

12.7 GENEWIZ 153

12.7.1 COMPANY OVERVIEW 153

12.7.2 FINANCIAL OVERVIEW 154

12.7.3 PRODUCTS/SERVICES OFFERED 154

12.7.4 KEY DEVELOPMENTS 155

12.7.5 SWOT ANALYSIS 155

12.7.6 KEY STRATEGIES 156

12.8 AMBRY GENETICS 157

12.8.1 COMPANY OVERVIEW 157

12.8.2 FINANCIAL OVERVIEW 157

12.8.3 PRODUCTS/SERVICES OFFERED 157

12.8.4 KEY DEVELOPMENTS 157

12.8.5 SWOT ANALYSIS 158

12.8.6 KEY STRATEGIES 158

12.9 MACROGEN, INC. 159

12.9.1 COMPANY OVERVIEW 159

12.9.2 FINANCIAL OVERVIEW 159

12.9.3 PRODUCTS/SERVICES OFFERED 159

12.9.4 KEY DEVELOPMENTS 159

12.9.5 SWOT ANALYSIS 160

12.9.6 KEY STRATEGIES 160

12.10 INTEGRAGEN SA 161

12.10.1 COMPANY OVERVIEW 161

12.10.2 FINANCIAL OVERVIEW 161

12.10.3 PRODUCTS/SERVICES OFFERED 161

12.10.4 KEY DEVELOPMENTS 162

12.10.5 SWOT ANALYSIS 162

12.10.6 KEY STRATEGIES 162

13 APPENDIX

13.1 REFERENCES 163

13.2 RELATED REPORTS 164

14 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 19

TABLE 2 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY PRODUCT 2020-2027 (USD MILLION) 39

TABLE 3 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 39

TABLE 4 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY REGION 2020-2027 (USD MILLION) 39

TABLE 5 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION KITS, BY REGION 2020-2027 (USD MILLION) 40

TABLE 6 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR LIBRARY PREPARATION, BY REGION 2020-2027 (USD MILLION) 40

TABLE 7 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR TARGET ENRICHMENT, BY REGION 2020-2027 (USD MILLION) 41

TABLE 8 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR SEQUENCER, BY REGION 2020-2027 (USD MILLION) 41

TABLE 9 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 42

TABLE 10 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY REGION 2020-2027 (USD MILLION) 42

TABLE 11 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR SEQUENCING SERVICES, BY REGION 2020-2027 (USD MILLION) 42

TABLE 12 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR DATA ANALYSIS (BIOINFORMATICS), BY REGION 2020-2027 (USD MILLION) 43

TABLE 13 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR OTHER SERVICES, BY REGION 2020-2027 (USD MILLION) 43

TABLE 14 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 45

TABLE 15 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR SEQUENCING BY SYNTHESIS (SBS), BY REGION 2020-2027 (USD MILLION) 45

TABLE 16 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR ION SEMICONDUCTOR SEQUENCING, BY REGION 2020-2027 (USD MILLION) 46

TABLE 17 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR OTHER TECHNOLOGYS, BY REGION 2020-2027 (USD MILLION) 46

TABLE 18 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY APPLICATION 2020-2027 (USD MILLION) 48

TABLE 19 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 48

TABLE 20 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY REGION 2020-2027 (USD MILLION) 49

TABLE 21 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR CANCER DIAGNOSTICS, BY REGION 2020-2027 (USD MILLION) 49

TABLE 22 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR MONOGENIC (MENDELIAN) DISORDERS, BY REGION 2020-2027 (USD MILLION) 50

TABLE 23 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR MONOGENIC TYPES OF DIABETES, BY REGION 2020-2027 (USD MILLION) 50

TABLE 24 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR MOVEMENT DISORDERS, BY REGION 2020-2027 (USD MILLION) 51

TABLE 25 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR HIV, BY REGION 2020-2027 (USD MILLION) 51

TABLE 26 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR OTHER DIAGNOSTICS, BY REGION 2020-2027 (USD MILLION) 52

TABLE 27 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION 2020-2027 (USD MILLION) 52

TABLE 28 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION 2020-2027 (USD MILLION) 53

TABLE 29 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR OTHER APPLICATIONS, BY REGION 2020-2027 (USD MILLION) 53

TABLE 30 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY END USER 2020-2027 (USD MILLION) 55

TABLE 31 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR RESEARCH CENTERS AND GOVERNMENT INSTITUTES, BY REGION 2020-2027 (USD MILLION) 55

TABLE 32 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR HOSPITALS AND DIAGNOSTICS CENTERS, BY REGION 2020-2027 (USD MILLION) 56

TABLE 33 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION 2020-2027 (USD MILLION) 56

TABLE 34 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR OTHER ENS USERS, BY REGION 2020-2027 (USD MILLION) 57

TABLE 35 GLOBAL: WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 59

TABLE 36 AMERICAS: WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 60

TABLE 37 AMERICAS: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 60

TABLE 38 AMERICAS: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 61

TABLE 39 AMERICAS: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 61

TABLE 40 AMERICAS: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 61

TABLE 41 AMERICAS: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62

TABLE 42 AMERICAS: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 62

TABLE 43 AMERICAS: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 63

TABLE 44 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 63

TABLE 45 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 64

TABLE 46 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 64

TABLE 47 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 64

TABLE 48 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 65

TABLE 49 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 50 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 65

TABLE 51 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 66

TABLE 52 US: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 66

TABLE 53 US: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 66

TABLE 54 US: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 67

TABLE 55 US: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 67

TABLE 56 US: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 67

TABLE 57 US: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 68

TABLE 58 US: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 68

TABLE 59 CANADA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 69

TABLE 60 CANADA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 69

TABLE 61 CANADA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 69

TABLE 62 CANADA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 70

TABLE 63 CANADA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 64 CANADA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 70

TABLE 65 CANADA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 71

TABLE 66 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 71

TABLE 67 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 71

TABLE 68 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 72

TABLE 69 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 72

TABLE 70 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72

TABLE 71 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 73

TABLE 72 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 73

TABLE 73 EUROPE WHOLE EXOME SEQUENCING MARKET, BY REGION 2020-2027 (USD MILLION) 74

TABLE 74 EUROPE: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 74

TABLE 75 EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 75

TABLE 76 EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 75

TABLE 77 EUROPE: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 75

TABLE 78 EUROPE: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 76

TABLE 79 EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 76

TABLE 80 EUROPE: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 76

TABLE 81 WESTERN EUROPE WHOLE EXOME SEQUENCING MARKET, BY COUNTRY 2020-2027 (USD MILLION) 77

TABLE 82 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 77

TABLE 83 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 78

TABLE 84 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 78

TABLE 85 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 78

TABLE 86 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 79

TABLE 87 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 79

TABLE 88 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 80

TABLE 89 GERMANY: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 80

TABLE 90 GERMANY: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 80

TABLE 91 GERMANY: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 81

TABLE 92 GERMANY: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 81

TABLE 93 GERMANY: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 81

TABLE 94 GERMANY: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 82

TABLE 95 GERMANY: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 82

TABLE 96 FRANCE: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 83

TABLE 97 FRANCE: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 83

TABLE 98 FRANCE: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 83

TABLE 99 FRANCE: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 84

TABLE 100 FRANCE: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 84

TABLE 101 FRANCE: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 84

TABLE 102 FRANCE: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 85

TABLE 103 UK: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 85

TABLE 104 UK: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 85

TABLE 105 UK: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 86

TABLE 106 UK: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 86

TABLE 107 UK: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86

TABLE 108 UK: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 87

TABLE 109 UK: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 87

TABLE 110 ITALY: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 88

TABLE 111 ITALY: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 88

TABLE 112 ITALY: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 88

TABLE 113 ITALY: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 89

TABLE 114 ITALY: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89

TABLE 115 ITALY: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 89

TABLE 116 ITALY: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 90

TABLE 117 SPAIN: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 90

TABLE 118 SPAIN: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 90

TABLE 119 SPAIN: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 91

TABLE 120 SPAIN: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 91

TABLE 121 SPAIN: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 91

TABLE 122 SPAIN: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 92

TABLE 123 SPAIN: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 92

TABLE 124 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93

TABLE 125 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 93

TABLE 126 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 93

TABLE 127 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 94

TABLE 128 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 94

TABLE 129 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 94

TABLE 130 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 95

TABLE 131 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 95

TABLE 132 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 95

TABLE 133 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 96

TABLE 134 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 96

TABLE 135 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 96

TABLE 136 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 97

TABLE 137 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 97

TABLE 138 ASIA-PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98

TABLE 139 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 99

TABLE 140 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 99

TABLE 141 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 99

TABLE 142 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 100

TABLE 143 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 100

TABLE 144 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 100

TABLE 145 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 101

TABLE 146 JAPAN: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101

TABLE 147 JAPAN: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 101

TABLE 148 JAPAN: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 102

TABLE 149 JAPAN: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 102

TABLE 150 JAPAN: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 102

TABLE 151 JAPAN: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 103

TABLE 152 JAPAN: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 103

TABLE 153 CHINA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104

TABLE 154 CHINA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 104

TABLE 155 CHINA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 104

TABLE 156 CHINA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 105

TABLE 157 CHINA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105

TABLE 158 CHINA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 105

TABLE 159 CHINA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 106

TABLE 160 INDIA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 106

TABLE 161 INDIA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 106

TABLE 162 INDIA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 107

TABLE 163 INDIA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 107

TABLE 164 INDIA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107

TABLE 165 INDIA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 108

TABLE 166 INDIA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 108

TABLE 167 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109

TABLE 168 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 109

TABLE 169 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 109

TABLE 170 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 110

TABLE 171 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110

TABLE 172 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 110

TABLE 173 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 111

TABLE 174 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 111

TABLE 175 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 111

TABLE 176 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 112

TABLE 177 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 112

TABLE 178 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 112

TABLE 179 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 113

TABLE 180 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 113

TABLE 181 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 114

TABLE 182 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 114

TABLE 183 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 114

TABLE 184 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 115

TABLE 185 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115

TABLE 186 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 115

TABLE 187 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 116

TABLE 188 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 117

TABLE 189 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 117

TABLE 190 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 118

TABLE 191 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 118

TABLE 192 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 118

TABLE 193 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119

TABLE 194 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 119

TABLE 195 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 120

TABLE 196 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 120

TABLE 197 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 120

TABLE 198 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 121

TABLE 199 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 121

TABLE 200 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121

TABLE 201 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 122

TABLE 202 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 122

TABLE 203 AFRICA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 123

TABLE 204 AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2020-2027 (USD MILLION) 123

TABLE 205 AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2020-2027 (USD MILLION) 123

TABLE 206 AFRICA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 124

TABLE 207 AFRICA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124

TABLE 208 AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2020-2027 (USD MILLION) 124

TABLE 209 AFRICA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 125

TABLE 210 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE WHOLE EXOME SEQUENCING MARKET 130

TABLE 211 COLLABORATIONS & PARTNERSHIPS: GLOBAL WHOLE EXOME SEQUENCING MARKET 130

TABLE 212 EXPANSIONS: GLOBAL WHOLE EXOME SEQUENCING MARKET 131

TABLE 213 ILLUMINA INC.: PRODUCTS/SERVICES OFFERED 135

TABLE 214 ILLUMINA INC.: KEY DEVELOPMENTS 135

TABLE 215 BGI: PRODUCTS/SERVICES OFFERED 138

TABLE 216 BGI: KEY DEVELOPMENTS 139

TABLE 217 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 141

TABLE 218 EUROFINS SCIENTIFIC: KEY DEVELOPMENTS 141

TABLE 219 THERMO FISHER SCIENTIFIC: PRODUCTS/SERVICES OFFERED 145

TABLE 220 THERMO FISHER SCIENTIFIC: KEY DEVELOPMENTS 145

TABLE 221 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 148

TABLE 222 AGILENT TECHNOLOGIES, INC.: KEY DEVELOPMENTS 148

TABLE 223 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED 151

TABLE 224 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS 152

TABLE 225 GENEWIZ: PRODUCTS/SERVICES OFFERED 154

TABLE 226 GENEWIZ: KEY DEVELOPMENTS 155

TABLE 227 AMBRY GENETICS: PRODUCTS/SERVICES OFFERED 157

TABLE 228 MACROGEN, INC.: PRODUCTS/SERVICES OFFERED 159

TABLE 229 INTEGRAGEN SA: PRODUCTS/SERVICES OFFERED 161

15 LIST OF FIGURES

FIGURE 1 GLOBAL WHOLE EXOME SEQUENCING MARKET STRUCTURE 20

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 26

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL WHOLE EXOME SEQUENCING MARKET 29

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL WHOLE EXOME SEQUENCING MARKET 34

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL WHOLE EXOME SEQUENCING MARKET 36

FIGURE 6 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY PRODUCT 2019 & 2027 (USD MILLION) 38

FIGURE 7 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY 2019 & 2027 (USD MILLION) 44

FIGURE 8 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY APPLICATION 2019 & 2027 (USD MILLION) 47

FIGURE 9 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY END USER 2019 & 2027 (USD MILLION) 54

FIGURE 10 GLOBAL WHOLE EXOME SEQUENCING MARKET SHARE, BY REGION 2019 & 2027 (USD MILLION) 59

FIGURE 11 AMERICAS: WHOLE EXOME SEQUENCING MARKET SHARE, BY REGION, 2019 (%) 60

FIGURE 12 NORTH AMERICAS: WHOLE EXOME SEQUENCING MARKET SHARE, BY REGION, 2019 (%) 63

FIGURE 13 EUROPE: WHOLE EXOME SEQUENCING MARKET SHARE, BY REGION, 2019 (%) 74

FIGURE 14 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET SHARE, BY REGION, 2019 (%) 77

FIGURE 15 ASIA-PACIFIC: WHOLE EXOME SEQUENCING MARKET SHARE, BY COUNTRY, 2019 (%) 98

FIGURE 16 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET SHARE, BY COUNTRY, 20209 (%) 117

FIGURE 17 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL WHOLE EXOME SEQUENCING MARKET 127

FIGURE 18 GLOBAL WHOLE EXOME SEQUENCING MARKET, MARKET SHARE ANALYSIS (% SHARE) 128

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS IN THE GLOBAL WHOLE EXOME SEQUENCING MARKET 129

FIGURE 20 SALES AND OPERATING PROFIT MARGIN, 2019 131

FIGURE 21 MAJOR PLAYERS R&D EXPENDITURE, 2019 132

FIGURE 22 ILLUMINA INC.: FINANCIAL OVERVIEW SNAPSHOT 134

FIGURE 23 ILLUMINA INC.: SWOT ANALYSIS 136

FIGURE 24 BGI: FINANCIAL OVERVIEW SNAPSHOT 138

FIGURE 25 BGI: SWOT ANALYSIS 139

FIGURE 26 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT 140

FIGURE 27 EUROFINS SCIENTIFIC: SWOT ANALYSIS 142

FIGURE 28 THERMO FISHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT 144

FIGURE 29 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS 146

FIGURE 30 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW 147

FIGURE 31 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS 149

FIGURE 32 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW 151

FIGURE 33 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 152

FIGURE 34 GENEWIZ: FINANCIAL OVERVIEW SNAPSHOT 154

FIGURE 35 GENEWIZ: SWOT ANALYSIS 155

FIGURE 36 AMBRY GENETICS: SWOT ANALYSIS 158

FIGURE 37 MACROGEN, INC.: SWOT ANALYSIS 160

FIGURE 38 INTEGRAGEN SA: FINANCIAL OVERVIEW SNAPSHOT 161

FIGURE 39 INTEGRAGEN SA: SWOT ANALYSIS 162

エクソームシークエンシング市場全体

エクソームシーケンシング市場全体の規模は 20.20% のCAGRを登録し、2030年までに7,00702万米ドルに達すると予想されています。

セグメンテーション

By Products Kits Sequencer Services
テクノロジー別 Sequencing By Synthesis (Sbs) Ion Semiconductor Sequencing
アプリケーション別 Diagnostics Drug Discovery And Development Agriculture And Animal Research

キープレーヤー

  • Illumina Inc. (US)
  • BGI (China)
  • Eurofins Scientific (Belgium)
  • Thermo Fisher Scientific (US)
  • Agilent Technologies Inc. (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • GENEWIZ (US)
  • Ambry Genetics (US )
  • Macrogen Inc. (South Korea)
  • Integragen SA (France)

運転手

  • Use of whole-exome sequencing technology for varied applications
  • Strategic alliances amongst key players & research institutes
  • lack of skilled professionals and ethical & legal issues related to whole-exome sequencing are hampering the growth of the market
Speak to Analyst Request a Free Sample

全エクソームシーケンス市場の概要


エクソームシーケンシング市場全体の規模は、2030年までに20.20%のCAGRで7,00702万米ドルに達すると予想されています。全エクソームシークエンシングは、主に個体関連配列のタンパク質コード領域のヌクレオチド配列を決定するために広く使用されている次世代シーケンス(NGS)法であり、完全なDNAの約1%に相当します。シーケンス。ヒトエクソームはゲノムの2%未満を占めるが、既知の疾患関連変異体の約85%を含む。これが、ミラー症候群やアルツハイマー病などのさまざまな疾患を引き起こす遺伝的変異の特定と決定にエクソームを使用する主な理由です。


市場の成長を促進する要因は、シーケンシングのコストの低下、さまざまなアプリケーションへの全エクソームシーケンシング技術の使用、および主要企業と研究機関間の戦略的提携です。しかし、熟練した専門家の不足と、全エクソームシーケンシングに関連する倫理的および法的問題が、市場の成長を妨げています。


全エクソームシーケンス市場のダイナミクス


エクソームシーケンス市場全体で事業を行っている市場プレーヤーは、市場での優位性を獲得し、製品を最新の状態に保ち、需要を維持するために、製品の発売、承認、およびパートナーシップに注力しています。たとえば、2019年11月、次世代の個別化ヘルスケア企業であるNanHealth, Inc.(US)は、腫瘍と体細胞遺伝子の両方を分析して全体を測定するために使用される最初の全エクソームシーケンサーであるOmicsCoreSMのFDA承認を受けましたがん組織における腫瘍変異負荷(TMB)。


全エクソームシーケンス市場細分化


エクソームシーケンシング市場全体は、製品、技術、アプリケーション、およびエンドユーザーに基づいて分割されています。市場は、製品に基づいて、キット、シーケンサー、およびサービスに分割されています。キットはさらに、DNA断片化、末端修復、Aテーリング、およびサイズ選択キット、ライブラリー調製、およびターゲット濃縮に分割されます。サービスはさらにシーケンシングサービス、データ分析(バイオインフォマティクス)、その他に細分化されています。世界の全エクソームシーケンシング市場は、技術によって、合成によるシーケンシング(SBS)、イオンセミコンダクターシーケンシングなどに分類されています。アプリケーション別の市場は、診断、創薬、開発、農業および動物研究などに分割されています。エンドユーザーに基づいて、市場は研究センターと政府機関、病院と診断センター、製薬およびバイオテクノロジー企業などに分割されています。


アジア太平洋全エクソームシーケンス市場シェア、国別、2019(%)Whole Exome Sequencing Market


ソース:MRFR 分析


全エクソームシーケンス市場の地域分析


南北アメリカは、2019年の全エクソームシーケンシングの最大の市場でした。南北アメリカ市場の成長は、がんやその他の慢性疾患の有病率が高く、医療費の増加によるものです。さらに、全エクソームシークエンシング技術の開発と採用に対する政府や他の組織による好意的なイニシアチブが、全エクソームシーケンシングの市場を牽引しています。たとえば、2018年、国立衛生研究所の一部であるAll of Us Research Programは、米国に3つのゲノムセンターを設立するために2,860万米ドル以上の資金を授与しました。これらのセンターは、研究者向けのゲノムデータと、さまざまな重要な健康問題に関する研究を支援する全国的なリソースであるプログラムの精密医療研究プラットフォームを作成することを目的としています。


ヨーロッパは全エクソームシーケンシングの第2位の市場であり、西ヨーロッパでは最大の市場シェアを保持しています。欧州市場は、がんの症例数の増加とゲノム配列決定の採用プログラムの増加により、予測期間中に堅調な成長率を記録すると予想されています。国際がん研究機関によると、2018年のヨーロッパでは約4,229,662例のがんがありました。がんのこの巨大な症例とゲノムマッピングプログラムの増加は、全エクソームシークエンシング市場の成長にプラスの影響を与えると予想されます。


アジア太平洋地域は、患者プールの増加と増加により、予測期間中で最も高い市場成長の可能性を示すと予想されます 技術の進歩。アジア太平洋地域の急速な成長は、医療の質を高めるための政府の取り組みとともに、一人当たりの所得の増加によるものです。中国、インド、オーストラリアは、高齢者の増加により、全エクソームシーケンシングの有利な市場を持っています。さらに、2015年に国連が発表した報告書によると、世界の60歳以上の高齢者の数は、2015年から2030年の間に56%増加すると予測されています。全世界人口のうち、高齢者人口の66%がアジア太平洋地域にも居住しています。


中東およびアフリカでは、エクソームシーケンス市場全体が大きな市場シェアを占めています。クウェート、アラブ首長国連邦、サウジアラビアなどの国は、がん症例の増加、患者ケアを改善するための政府によるイニシアチブの増加、および有利な償還政策により、着実な成長を示す可能性があります。しかし、中東とアフリカの他の地域では、手頃な価格とアクセシビリティの問題により、活発でない成長を示す可能性があります。


全エクソームシーケンス市場の主要プレーヤー


世界の全エクソームシーケンシング市場で著名なプレーヤーは、イルミナ社(米国)、BGI(中国)、ユーロフィンサイエンティフィック(ベルギー)、サーモフィッシャーサイエンティフィック(米国)、アジレントテクノロジーズ(米国)、F.ホフマンラロッシュ株式会社(スイス)、GENEWIZ(米国)、Ambry Genetics(米国)、Macrogen、Inc.(韓国))、インテグラゲンSA(フランス)、その他。


市場細分化


エクソームシーケンス市場全体、製品別



  • キット


    • DNA断片化、末端修復、Aテーリング、およびサイズ選択キット

    • 図書館の準備

    • ターゲットエンリッチメント


  • シーケンサー

  • サービス


    • シーケンスサービス

    • データ分析 (バイオインフォマティクス)

    • その他



エクソームシーケンス市場全体、テクノロジー別



  • 合成によるシークエンシング (SBS)

  • イオン半導体シーケンシング

  • その他


エクソームシーケンス市場全体、アプリケーション別



  • 診断


    • がん診断

    • 単一遺伝性(メンデル)障害

    • 単一遺伝子型糖尿病

    • 運動障害

    • HIV

    • その他


  • 創薬と開発

  • 農業と動物研究

  • その他


エクソームシーケンス市場全体、エンドユーザー別



  • 研究センターと政府機関

  • 病院と診断センター

  • 製薬およびバイオテクノロジー企業

  • その他


エクソームシーケンス市場全体、地域別



  • アメリカ


    • 北米

    • ラテンアメリカ




  • ヨーロッパ


    • 西ヨーロッパ


      • ドイツ

      • フランス

      • 英国

      • イタリア

      • スペイン

      • 西ヨーロッパのその他の地域


    • 東ヨーロッパ




  • アジアパシフィック


    • 中国

    • 日本

    • インド

    • オーストラリア

    • 韓国

    • その他のアジア太平洋




  • 中東 & アフリカ


    • 中東

    • アフリカ



利用可能な追加のカスタマイズ



  • さらに5人のプレイヤーの会社概要

  • 価格分析

  • 規制関連業務


対象読者



  • 政府、協会、産業団体

  • 投資家と貿易専門家

  • 医学研究室

  • 研究開発 (R&D) 企業

  • 市場調査およびコンサルティングサービスプロバイダー

  • 潜在的な投資家



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 7,007.02 Million
  CAGR   20.20%
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Services, Technology, Application and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Illumina Inc. (US), BGI (China), Eurofins Scientific (Belgium), Thermo Fisher Scientific (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GENEWIZ (US), Ambry Genetics (US ), Macrogen, Inc. (South Korea), Integragen SA (France)
  Key Market Opportunities   Decreasing cost of sequencing
  Key Market Drivers

  • Use of whole-exome sequencing technology for varied applications
  • strategic alliances amongst key players & research institutes
  • lack of skilled professionals and ethical & legal issues related to whole-exome sequencing are hampering the growth of the market


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The Whole Exome Sequencing market can expand at 20.20% CAGR by 2030.

    By 2030, the Whole Exome Sequencing market value can be above USD 7,007.02 Mn

    GENEWIZ (US), Macrogen, Inc. (South Korea), Ambry Genetics (US), and Integragen SA (France) are some reputed names in the Whole Exome Sequencing market.

    The increase in R&D for next-generation sequencing method can promote the Whole Exome Sequencing market.

    The lack of expertise can restrain Whole Exome Sequencing market.